Search research articles
Contact Us
Filters
Showing results (131-140 of 149) with videos related to
Page
of 15
Sort By:
Leukemia & Lymphoma
|
August 18, 2021
COVID-19 among patients with hematological malignancies: a national Israeli retrospective analysis with special emphasis on treatment and outcome
Ilana Levy, Avital Lavi, Eran Zimran, et al.
Journal of Cellular and Molecular Medicine
|
October 22, 2025
CD19 CAR T-Cell Therapy in Richter Transformation: A Multicentre Retrospective Analysis by the European Research Initiative on Chronic Lymphocytic Leukaemia
Ofrat Beyar-Katz, Ohad Benjamini, Julio Delgado, et al.
Blood
|
August 27, 2025
The impact of fitness and dose intensity on clinical outcomes with venetoclax-obinutuzumab in CLL
Othman Al-Sawaf, Moritz Fürstenau, Adam Giza, et al.
European Journal of Cancer (Oxford, England : 1990)
|
April 30, 2016
Combination of bendamustine and rituximab as front-line therapy for patients with chronic lymphocytic leukaemia: multicenter, retrospective clinical practice experience with 279 cases outside of controlled clinical trials
Massimo Gentile, Katja Zirlik, Stefania Ciolli, et al.
Leukemia
|
July 22, 2018
Moxetumomab pasudotox in relapsed/refractory hairy cell leukemia
Robert J Kreitman, Claire Dearden, Pier Luigi Zinzani, et al.
Leukemia
|
May 5, 2021
Hairy cell leukemia and COVID-19 adaptation of treatment guidelines
Michael Grever, Leslie Andritsos, Versha Banerji, et al.
Leukemia & Lymphoma
|
September 7, 2022
Development of a distributed international patient data registry for hairy cell leukemia
Leslie A Andritsos, Mirela Anghelina, Jasmine Neal, et al.
Blood
|
December 2, 2016
Consensus guidelines for the diagnosis and management of patients with classic hairy cell leukemia
Michael R Grever, Omar Abdel-Wahab, Leslie A Andritsos, et al.
The Lancet. Oncology
|
May 31, 2024
First-line venetoclax combinations versus chemoimmunotherapy in fit patients with chronic lymphocytic leukaemia (GAIA/CLL13): 4-year follow-up from a multicentre, open-label, randomised, phase 3 trial
Moritz Fürstenau, Arnon P Kater, Sandra Robrecht, et al.
Blood Cancer Journal
|
December 12, 2022
Consensus opinion from an international group of experts on measurable residual disease in hairy cell leukemia
Farhad Ravandi, Robert J Kreitman, Enrico Tiacci, et al.
Page
of 15
Search research articles
Search
Showing results (131-140 of 149) with videos related to
Sort By:
Page
of 15
Leukemia & Lymphoma
|
August 18, 2021
COVID-19 among patients with hematological malignancies: a national Israeli retrospective analysis with special emphasis on treatment and outcome
Ilana Levy, Avital Lavi, Eran Zimran, et al.
Journal of Cellular and Molecular Medicine
|
October 22, 2025
CD19 CAR T-Cell Therapy in Richter Transformation: A Multicentre Retrospective Analysis by the European Research Initiative on Chronic Lymphocytic Leukaemia
Ofrat Beyar-Katz, Ohad Benjamini, Julio Delgado, et al.
Blood
|
August 27, 2025
The impact of fitness and dose intensity on clinical outcomes with venetoclax-obinutuzumab in CLL
Othman Al-Sawaf, Moritz Fürstenau, Adam Giza, et al.
European Journal of Cancer (Oxford, England : 1990)
|
April 30, 2016
Combination of bendamustine and rituximab as front-line therapy for patients with chronic lymphocytic leukaemia: multicenter, retrospective clinical practice experience with 279 cases outside of controlled clinical trials
Massimo Gentile, Katja Zirlik, Stefania Ciolli, et al.
Leukemia
|
July 22, 2018
Moxetumomab pasudotox in relapsed/refractory hairy cell leukemia
Robert J Kreitman, Claire Dearden, Pier Luigi Zinzani, et al.
Leukemia
|
May 5, 2021
Hairy cell leukemia and COVID-19 adaptation of treatment guidelines
Michael Grever, Leslie Andritsos, Versha Banerji, et al.
Leukemia & Lymphoma
|
September 7, 2022
Development of a distributed international patient data registry for hairy cell leukemia
Leslie A Andritsos, Mirela Anghelina, Jasmine Neal, et al.
Blood
|
December 2, 2016
Consensus guidelines for the diagnosis and management of patients with classic hairy cell leukemia
Michael R Grever, Omar Abdel-Wahab, Leslie A Andritsos, et al.
The Lancet. Oncology
|
May 31, 2024
First-line venetoclax combinations versus chemoimmunotherapy in fit patients with chronic lymphocytic leukaemia (GAIA/CLL13): 4-year follow-up from a multicentre, open-label, randomised, phase 3 trial
Moritz Fürstenau, Arnon P Kater, Sandra Robrecht, et al.
Blood Cancer Journal
|
December 12, 2022
Consensus opinion from an international group of experts on measurable residual disease in hairy cell leukemia
Farhad Ravandi, Robert J Kreitman, Enrico Tiacci, et al.
Page
of 15